Endo Targets Opana ER Abuse-Deterrent Filing In 2016
This article was originally published in The Pink Sheet Daily
Executive Summary
Endo continues to believe it can rebuild Opana ER, despite generic competition, by adding abuse-deterrent labeling and securing critical intellectual property protection.